Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Though most people recover from the ...

Nearly one in six U.S. children received at least one vaccine dose outside the recommended age guidelines during a recent ...

Many of the county’s healthcare and business leaders gathered in Inova Loudoun Hospital’s North Tower on Friday to celebrate ...

Overall, 15.4% of children aged 0 to 35 months receive an invalid vaccine dose, receiving a vaccine earlier or later than ...

Describing Elena as "pretty hands-on," Greg admitted his wife often jokes that he’s "terrible at everything" because he’s ...

“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or ...

Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads ...

A third dose of COVID-19 vaccine is beneficial among older Medicare beneficiaries, regardless of prior medically attended COVID-19 diagnoses.

The United States has agreed to purchase 66 million doses of Moderna’s bivalent COVID-19 booster candidate for $1.74 billion.

Moderna appears attractive compared to the industry. Going by the price/sales (P/S) ratio, the company’s shares currently trade at 3.09, trailing 12-month sales value, lower than 6.61 for the ...